TABLE 4.
CRs Univariate and Multivariate Analyses of Predictors of Exclusion From LT
| Predictor Variables | HR (95% CI) | P Value |
|---|---|---|
| Univariate analysis | ||
| Age at T1 diagnosis (per year) | 0.99 (0.95-1.04) | 0.73 |
| Sex, female | 0.68 (0.23-2.00) | 0.49 |
| Race/ethnicity (versus Caucasian) | ||
| Hispanic | 1.90 (0.57-6.35) | 0.30 |
| African American | 1.64 (0.22-12.24) | 0.63 |
| Asian | 0.96 (0.32-2.90) | 0.94 |
| Diagnosis of liver disease (versus HCV) | ||
| Alcohol | 1.99 (0.41-9.73) | 0.40 |
| HBV | 0.91 (0.29-2.81) | 0.86 |
| NASH | 0.47 (0.06-3.81) | 0.48 |
| CTP score (per point) | 0.92 (0.68-1.24) | 0.60 |
| MELD score (per point) | 0.95 (0.82-1.11) | 0.55 |
| Tumor size at T1 diagnosis (per cm) | 1.64 (0.29-9.37) | 0.58 |
| AFP at T1 diagnosis | ||
| ≥20 (versus<20) | 2.09 (0.72-6.11) | 0.18 |
| ≥100 (versus<100) | 2.07 (0.58-7.30) | 0.26 |
| ≥500 (versus<500) | 6.90 (1.66-28.70) | 0.008 |
| Hypovascularity | 1.30 (0.31-5.46) | 0.72 |
| Absence of washout | 0.82 (0.27-2.47) | 0.72 |
| Rapid tumor progression* | 4.12 (1.61-10.53) | 0.003 |
| Multivariate analysis | ||
| AFP≥500 (versus<500) | 12.69 (2.82-57.01) | 0.001 |
| Rapid tumor progression* | 5.68 (2.20-14.64) | <0.001 |
Defined as>1 cm increase in total tumor diameter over 3 months.